Tae Yang 3C Co., Ltd. (XKON:052960)

Kronos Bio Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Aug 1, 2025	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017
Debt / Equity Ratio	0.39	0.39	0.24	0.11	0.23	0.08
Debt / EBITDA Ratio	5.08	5.08	7.31	1.28	2.69	0.63
Debt / FCF Ratio	13.57	13.57	2.94	0.54	1.50	-
Asset Turnover	1.16	1.16	1.15	1.50	1.62	1.81
Inventory Turnover	8.46	8.46	7.41	8.37	8.18	8.40
Quick Ratio	1.32	1.32	1.70	1.20	0.99	1.62
Current Ratio	1.88	1.88	2.19	1.73	1.49	2.40
Return on Equity (ROE)	8.87%	8.87%	4.76%	9.27%	7.18%	10.64%
Return on Assets (ROA)	2.58%	2.58%	0.68%	2.62%	2.72%	4.64%
Return on Capital (ROIC)	3.17%	3.17%	0.91%	3.62%	3.72%	6.43%
Return on Capital Employed (ROCE)	5.10%	5.10%	1.50%	6.40%	6.50%	10.50%
Payout Ratio	0.47%	0.47%	7.09%	3.89%	6.00%	1.36%
Buyback Yield / Dilution	11.46%	0.17%	-0.17%	4.41%	7.38%	-0.06%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.